Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Despite significant efforts, no therapies have demonstrated valuable survival benefit beyond the current standard of care. Immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape and improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Persico, Pasquale, Lorenzi, Elena, Dipasquale, Angelo, Pessina, Federico, Navarria, Pierina, Politi, Letterio S., Santoro, Armando, Simonelli, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036455/
https://www.ncbi.nlm.nih.gov/pubmed/33810532
http://dx.doi.org/10.3390/jcm10071367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036455/
https://www.ncbi.nlm.nih.gov/pubmed/33810532
http://dx.doi.org/10.3390/jcm10071367

Ejemplares similares